
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















Evaluation of median Time For complete discontinuation of UF Heparin and LMWH in venous Thromboembolism patients at tertiary care hosptals
Author(s) | Dr. Riona Mathew, Dr. Jincy Elsam John, Dr. Namitha Rachael Biji, Prof. Dr. Elessy Abraham |
---|---|
Country | India |
Abstract | Venous Thromboembolism (VTE) presents a significant clinical challenge in tertiary care, requiring prompt and effective anticoagulation therapy. Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) are common therapeutic options, but their relative efficacy in this context remains debated. We conducted a retrospective study of patients diagnosed with VTE in our tertiary care facility over a six- month period. Patients were stratified into two groups based on their initial anticoagulation therapy: UFH or LMWH. The main outcome assessed was median time taken for complete stoppage of both the anticoagulants. Among the included patients (n=96), 53 were females and 43 were males. Out of which 36.46% received UFH and 63.54% received LMWH as initial therapy. The median time taken for complete stoppage of overall treatment with UF heparin was 26 weeks (6.5 months) and LMWH was 22 weeks (5.5 months). The study reinforces the finding that UFH treatment might require a longer duration (almost a month) compared to LMWH for complete stoppage. Thus, considering certain factors like cost, treatment duration and de-escalation protocols, UFH emerges to be a more advisable option in clinical practice especially in low- resource setting where cost is the main concern |
Keywords | Key-words- Venous Thromboembolism, Unfractionated Heparin, low molecular weight heparin |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 4, July-August 2025 |
Published On | 2025-08-01 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.52633 |
Short DOI | https://doi.org/g9vzkz |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
